Dr Kim Agnew - CEO/Founder, Dr Rob Hunter - CSO
Background polymer technology developed by Pendant BioSciences (Shawn Glinter CEO/Founder).
Sorensis will introduce next generation polymer technology into the Animal Health industry which will provide an unparalleled level of tunable functionality in matching polymer matrix to the API (Active Pharmaceutical Ingredient). Slow-release technology has enormous potential to improve owner compliance with medications, allow therapeutic levels of selected actives to be maintained for extended periods and offer novel delivery systems into hard to effectively medicate spaces (e.g eyes, joints).
Sorensis is species agnostic but we do have specific expertise either in house or externally available in bovine, canine, feline and equine.
Company Details
- Employees
- 1
- Founded
- 2021
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.sorensis.com
Sorensis Pty Ltd Questions
Sorensis Pty Ltd's website is https://www.sorensis.com
Sorensis Pty Ltd's LinkedIn profile is https://www.linkedin.com/company/sorensis-pty-ltd
Sorensis Pty Ltd has
1 employees.
View email and phone details for 1
employees at Sorensis Pty Ltd.
Sorensis Pty Ltd's industry is
Pharmaceutical Manufacturing
Sorensis Pty Ltd's top competitors are
Roam Agricultural,
Ceres & Co,
Moovement,
Terracipher,
Lleaf Greenhouse Film Technology,
Mobble,
Airagri,
Veterinary Health Research Centers Llc,
Tomorrow Studio Ventures,
Giago.
Sorensis Pty Ltd's categories are Pharmaceutical Manufacturing
Sorensis Pty Ltd's founding year is 2021
